APA (7th ed.) Citation

BR, R., NK, L., EJ, M., PS, D., DJ, H., PA, D., . . . PJ, C. (2014). Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. The Journal of neuroscience : the official journal of the Society for Neuroscience, 34(23), 8021. https://doi.org/10.1523/JNEUROSCI.4196-13.2014

Chicago Style (17th ed.) Citation

BR, Roberts, et al. "Oral Treatment with Cu(II)(atsm) Increases Mutant SOD1 in Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis." The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 34, no. 23 (2014): 8021. https://doi.org/10.1523/JNEUROSCI.4196-13.2014.

MLA (9th ed.) Citation

BR, Roberts, et al. "Oral Treatment with Cu(II)(atsm) Increases Mutant SOD1 in Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis." The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, vol. 34, no. 23, 2014, p. 8021, https://doi.org/10.1523/JNEUROSCI.4196-13.2014.